Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Quantification of DNA Damage in Heart Tissue as a Novel Prediction Tool for Therapeutic Prognosis of Patients With Dilated Cardiomyopathy.

Ko T, Fujita K, Nomura S, Uemura Y, Yamada S, Tobita T, Katoh M, Satoh M, Ito M, Domoto Y, Hosoya Y, Amiya E, Hatano M, Morita H, Fukayama M, Aburatani H, Komuro I.

JACC Basic Transl Sci. 2019 Sep 25;4(6):670-680. doi: 10.1016/j.jacbts.2019.05.010. eCollection 2019 Oct.

2.

Variable Cardiac Responses to Immunosuppressive Therapy in Anti-Mitochondrial Antibody-Positive Myositis.

Bujo S, Amiya E, Kojima T, Yamada S, Maki H, Ishizuka M, Uehara M, Hosoya Y, Hatano M, Kubota A, Toda T, Komuro I.

Can J Cardiol. 2019 Nov;35(11):1604.e9-1604.e12. doi: 10.1016/j.cjca.2019.07.002. Epub 2019 Jul 11.

PMID:
31587935
3.

Significant impact of left ventricular assist device models on the value of flow-mediated dilation: effects of LVAD on endothelial function.

Watanabe A, Amiya E, Hatano M, Watanabe M, Ozeki A, Nitta D, Maki H, Hosoya Y, Tsuji M, Bujo C, Saito A, Endo M, Kagami Y, Nemoto M, Nawata K, Kinoshita O, Kimura M, Ono M, Komuro I.

Heart Vessels. 2019 Jul 20. doi: 10.1007/s00380-019-01474-2. [Epub ahead of print]

PMID:
31327031
4.

Correction to: The potential of cardiac rehabilitation as a method of suppressing abdominal aortic aneurysm expansion: a pilot study.

Nakayama A, Amiya E, Morita H, Hyodo K, Takayama N, Konishi Y, Taya M, Fujiwara T, Hosoya Y, Hoshina K, Komuro I.

Heart Vessels. 2019 Dec;34(12):2040. doi: 10.1007/s00380-019-01470-6.

PMID:
31297638
5.

Clinical impact of newly developed atrial fibrillation complicated with longstanding ventricular fibrillation during left ventricular assist device support: A case report.

Bujo C, Amiya E, Hatano M, Tsuji M, Maki H, Hosoya Y, Fujii E, Kamon T, Kojima T, Nawata K, Kinoshita O, Kimura M, Ono M, Komuro I.

BMC Cardiovasc Disord. 2019 Jun 21;19(1):151. doi: 10.1186/s12872-019-1132-1.

6.

Comment on "Improved Nutrition Status in Patients with Advanced Heart Failure Implanted with a Left Ventricular Assist Device" and Correlation Between Venous Congestion and Nutrition State.

Saito A, Amiya E, Hatano M.

Nutr Clin Pract. 2019 Oct;34(5):789. doi: 10.1002/ncp.10322. Epub 2019 Jun 7. No abstract available.

PMID:
31172558
7.

The potential of cardiac rehabilitation as a method of suppressing abdominal aortic aneurysm expansion: a pilot study.

Nakayama A, Amiya E, Morita H, Hyodo K, Takayama N, Konishi Y, Taya M, Fujiwara T, Hosoya Y, Hoshina K, Komuro I.

Heart Vessels. 2019 Dec;34(12):2031-2039. doi: 10.1007/s00380-019-01441-x. Epub 2019 May 29. Erratum in: Heart Vessels. 2019 Jul 11;:.

PMID:
31144100
8.

Progressive Right Ventricular Aneurysm in a Patient with Systemic Sarcoidosis.

Hirose K, Amiya E, Ishizuka M, Uehara M, Komuro I.

J Cardiovasc Imaging. 2019 Apr;27(2):158-161. doi: 10.4250/jcvi.2019.27.e18. No abstract available.

9.

Abdominal skeletal muscle mass as a predictor of mortality in Japanese patients undergoing left ventricular assist device implantation.

Tsuji M, Amiya E, Hatano M, Nitta D, Maki H, Bujo C, Saito A, Hosoya Y, Minatsuki S, Hara T, Nemoto M, Kagami Y, Endo M, Kimura M, Kinoshita O, Nawata K, Morita H, Ono M, Komuro I.

ESC Heart Fail. 2019 Jun;6(3):526-535. doi: 10.1002/ehf2.12429. Epub 2019 Mar 30.

10.

Controlling Nutritional Status Score As a Predictive Marker for Patients With Implantable Left Ventricular Assist Device.

Saito A, Amiya E, Hatano M, Shiraishi Y, Nitta D, Minatsuki S, Maki H, Hosoya Y, Tsuji M, Bujo C, Nawata K, Kinoshita O, Kimura M, Endo M, Kagami Y, Nemoto M, Ikeda Y, Morita H, Ono M, Komuro I.

ASAIO J. 2019 Feb 21. doi: 10.1097/MAT.0000000000000972. [Epub ahead of print]

PMID:
30913100
11.

Emergency percutaneous coronary intervention for left main trunk thrombus following orthotopic heart transplantation.

Tsuji M, Nitta D, Minatsuki S, Maki H, Hosoya Y, Amiya E, Hatano M, Takimoto E, Kinoshita O, Nawata K, Ono M, Komuro I.

ESC Heart Fail. 2019 Jun;6(3):575-578. doi: 10.1002/ehf2.12422. Epub 2019 Mar 10.

12.

Enormous Aneurysm in Coronary Artery Fistula With Immunoglobulin G4-Related Disease.

Kadowaki H, Amiya E, Hoshino Y, Tamura M, Uehara M, Nakayama A, Nawata K, Domoto Y, Saeki T, Ono M, Komuro I.

Can J Cardiol. 2019 Feb;35(2):230.e1-230.e3. doi: 10.1016/j.cjca.2018.11.030. Epub 2018 Dec 5.

PMID:
30760436
13.

Influence of atrial fibrillation on oxygen uptake and exercise tolerance in cardiovascular patients; close association with heart rate response.

Takano N, Amiya E, Oguri G, Nakayama A, Taya M, Nakajima T, Morita H, Komuro I.

Int J Cardiol Heart Vasc. 2019 Jan 8;22:84-91. doi: 10.1016/j.ijcha.2018.12.014. eCollection 2019 Mar.

14.

Genetic determinants and an epistasis of LILRA3 and HLA-B*52 in Takayasu arteritis.

Terao C, Yoshifuji H, Matsumura T, Naruse TK, Ishii T, Nakaoka Y, Kirino Y, Matsuo K, Origuchi T, Shimizu M, Maejima Y, Amiya E, Tamura N, Kawaguchi T, Takahashi M, Setoh K, Ohmura K, Watanabe R, Horita T, Atsumi T, Matsukura M, Miyata T, Kochi Y, Suda T, Tanemoto K, Meguro A, Okada Y, Ogimoto A, Yamamoto M, Takahashi H, Nakayamada S, Saito K, Kuwana M, Mizuki N, Tabara Y, Ueda A, Komuro I, Kimura A, Isobe M, Mimori T, Matsuda F.

Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):13045-13050. doi: 10.1073/pnas.1808850115. Epub 2018 Nov 29.

15.

Effect of Sympatholytic Therapy on Circadian Cardiac Autonomic Activity in Non-Diabetic Chronic Kidney Disease.

Makimoto H, Shimizu K, Fujiu K, Lin T, Oshima T, Amiya E, Yamagata K, Kojima T, Daimon M, Nagatomo R, Waki K, Meyer C, Komuro I.

Int Heart J. 2018 Nov 28;59(6):1352-1358. doi: 10.1536/ihj.17-561. Epub 2018 Oct 25.

16.

Single-Nucleotide Polymorphism of the MLX Gene Is Associated With Takayasu Arteritis.

Tamura N, Maejima Y, Matsumura T, Vega RB, Amiya E, Ito Y, Shiheido-Watanabe Y, Ashikaga T, Komuro I, Kelly DP, Hirao K, Isobe M.

Circ Genom Precis Med. 2018 Oct;11(10):e002296. doi: 10.1161/CIRCGEN.118.002296.

17.

A Useful Scoring System For Predicting Right Ventricular Assist Device Requirement Among Patients with a Paracorporeal Left Ventricular Assist Device.

Nitta D, Kinugawa K, Imamura T, Amiya E, Hatano M, Kinoshita O, Nawata K, Ono M, Komuro I.

Int Heart J. 2018 Sep 26;59(5):983-990. doi: 10.1536/ihj.17-487. Epub 2018 Aug 29.

18.

Impact of Pathogenic FBN1 Variant Types on the Progression of Aortic Disease in Patients With Marfan Syndrome.

Takeda N, Inuzuka R, Maemura S, Morita H, Nawata K, Fujita D, Taniguchi Y, Yamauchi H, Yagi H, Kato M, Nishimura H, Hirata Y, Ikeda Y, Kumagai H, Amiya E, Hara H, Fujiwara T, Akazawa H, Suzuki JI, Imai Y, Nagai R, Takamoto S, Hirata Y, Ono M, Komuro I.

Circ Genom Precis Med. 2018 Jun;11(6):e002058. doi: 10.1161/CIRCGEN.117.002058.

PMID:
29848614
19.

Prevalence of primary Sjögren's syndrome in patients undergoing evaluation for pulmonary arterial hypertension.

Sato T, Hatano M, Iwasaki Y, Maki H, Saito A, Minatsuki S, Inaba T, Amiya E, Fujio K, Watanabe M, Yamamoto K, Komuro I.

PLoS One. 2018 May 15;13(5):e0197297. doi: 10.1371/journal.pone.0197297. eCollection 2018.

20.

High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial.

Taguchi I, Iimuro S, Iwata H, Takashima H, Abe M, Amiya E, Ogawa T, Ozaki Y, Sakuma I, Nakagawa Y, Hibi K, Hiro T, Fukumoto Y, Hokimoto S, Miyauchi K, Yamazaki T, Ito H, Otsuji Y, Kimura K, Takahashi J, Hirayama A, Yokoi H, Kitagawa K, Urabe T, Okada Y, Terayama Y, Toyoda K, Nagao T, Matsumoto M, Ohashi Y, Kaneko T, Fujita R, Ohtsu H, Ogawa H, Daida H, Shimokawa H, Saito Y, Kimura T, Inoue T, Matsuzaki M, Nagai R.

Circulation. 2018 May 8;137(19):1997-2009. doi: 10.1161/CIRCULATIONAHA.117.032615. Erratum in: Circulation. 2019 Apr 2;139(14):e836.

21.

Effect of Oral Branched-Chain Amino Acids on Serum Albumin Concentration in Heart Failure Patients with Hypoalbuminemia: Results of a Preliminary Study.

Uchino Y, Watanabe M, Takata M, Amiya E, Tsushima K, Adachi T, Hiroi Y, Funazaki T, Komuro I.

Am J Cardiovasc Drugs. 2018 Aug;18(4):327-332. doi: 10.1007/s40256-018-0269-0.

22.

Correction to: High-intensity aerobic interval training can lead to improvement in skeletal muscle power among in-hospital patients with advanced heart failure.

Taya M, Amiya E, Hatano M, Maki H, Nitta D, Saito A, Tsuji M, Hosoya Y, Minatsuki S, Nakayama A, Fujiwara T, Konishi Y, Yokota K, Watanabe M, Morita H, Haga N, Komuro I.

Heart Vessels. 2018 Jul;33(7):760-761. doi: 10.1007/s00380-018-1132-6.

PMID:
29464340
23.

Genetic basis of cardiomyopathy and the genotypes involved in prognosis and left ventricular reverse remodeling.

Tobita T, Nomura S, Fujita T, Morita H, Asano Y, Onoue K, Ito M, Imai Y, Suzuki A, Ko T, Satoh M, Fujita K, Naito AT, Furutani Y, Toko H, Harada M, Amiya E, Hatano M, Takimoto E, Shiga T, Nakanishi T, Sakata Y, Ono M, Saito Y, Takashima S, Hagiwara N, Aburatani H, Komuro I.

Sci Rep. 2018 Jan 31;8(1):1998. doi: 10.1038/s41598-018-20114-9.

24.

High-intensity aerobic interval training can lead to improvement in skeletal muscle power among in-hospital patients with advanced heart failure.

Taya M, Amiya E, Hatano M, Maki H, Nitta D, Saito A, Tsuji M, Hosoya Y, Minatsuki S, Nakayama A, Fujiwara T, Konishi Y, Yokota K, Watanabe M, Morita H, Haga N, Komuro I.

Heart Vessels. 2018 Jul;33(7):752-759. doi: 10.1007/s00380-018-1120-x. Epub 2018 Jan 15. Erratum in: Heart Vessels. 2018 Feb 20;:.

PMID:
29335797
25.

Is Exercise Training Appropriate for Patients With Advanced Heart Failure Receiving Continuous Inotropic Infusion? A Review.

Amiya E, Taya M.

Clin Med Insights Cardiol. 2018 Jan 3;12:1179546817751438. doi: 10.1177/1179546817751438. eCollection 2018. Review.

26.

Newly developed atrial fibrillation progresses to a more severe INTERMACS score in a patient with advanced heart failure due to dilated cardiomyopathy.

Saito A, Amiya E, Hatano M, Hosoya Y, Maki H, Nitta D, Minatsuki S, Watanabe M, Komuro I.

Clin Case Rep. 2017 Nov 1;5(12):2028-2033. doi: 10.1002/ccr3.1247. eCollection 2017 Dec.

27.

Usefulness of central venous saturation as a predictor of thiamine deficiency in critically ill patients: a case report.

Numata G, Kodera S, Kiriyama H, Nakayama A, Amiya E, Kiyosue A, Hatano M, Takimoto E, Watanabe M, Komuro I.

J Intensive Care. 2017 Nov 6;5:61. doi: 10.1186/s40560-017-0255-7. eCollection 2017.

28.

Successful bridge to recovery in fulminant myocarditis using a biventricular assist device: a case report.

Adachi Y, Kinoshita O, Hatano M, Shintani Y, Naito N, Kimura M, Nawata K, Nitta D, Maki H, Ueda K, Amiya E, Takimoto E, Komuro I, Ono M.

J Med Case Rep. 2017 Oct 24;11(1):295. doi: 10.1186/s13256-017-1466-1.

29.

Dilated cardiomyopathy complicated with visceral heterotaxy.

Tsuji M, Amiya E, Hatano M, Komuro I.

Eur Heart J. 2018 Jan 1;39(1):73. doi: 10.1093/eurheartj/ehx593. No abstract available.

PMID:
29040450
30.

Cardiac Resynchronization Therapy in Patients with Ebstein's Anomaly.

Numata G, Amiya E, Kojima T, Fujiu K, Hatano M, Watanabe M, Komuro I.

Int Heart J. 2017 Oct 21;58(5):816-819. doi: 10.1536/ihj.16-580. Epub 2017 Sep 30.

31.

Readmissions after continuous flow left ventricular assist device implantation.

Kimura M, Nawata K, Kinoshita O, Yamauchi H, Hoshino Y, Hatano M, Amiya E, Kashiwa K, Endo M, Kagami Y, Nemoto M, Ono M.

J Artif Organs. 2017 Dec;20(4):311-317. doi: 10.1007/s10047-017-0975-4. Epub 2017 Jul 27.

PMID:
28752193
32.

An exploratory study on the efficacy and safety of a BCAA preparation used in combination with cardiac rehabilitation for patients with chronic heart failure.

Takata M, Amiya E, Watanabe M, Hosoya Y, Nakayama A, Fujiwara T, Taya M, Oguri G, Hyodo K, Takayama N, Takano N, Mashiko T, Uemura Y, Komuro I.

BMC Cardiovasc Disord. 2017 Jul 27;17(1):205. doi: 10.1186/s12872-017-0639-6.

33.

Authors' reply to the Drs. Finsterer and Zarrouk-Mahjoub's comments for our case report.

Amiya E, Morita H, Ishiura H, Tsuji S, Komuro I.

Int J Cardiol. 2018 Mar 1;254:262. doi: 10.1016/j.ijcard.2017.06.111. Epub 2017 Jun 30. No abstract available.

PMID:
28697867
34.

Rapid Improvement of thyroid storm-related hemodynamic collapse by aggressive anti-thyroid therapy including steroid pulse: A case report.

Kiriyama H, Amiya E, Hatano M, Hosoya Y, Maki H, Nitta D, Saito A, Shiraishi Y, Minatsuki S, Sato T, Murakami H, Uehara M, Manaka K, Makita N, Watanabe M, Komuro I.

Medicine (Baltimore). 2017 Jun;96(22):e7053. doi: 10.1097/MD.0000000000007053.

35.

ICD for Patients With Severe Renal Dysfunction.

Amiya E.

Int Heart J. 2017 May 31;58(3):303-304. doi: 10.1536/ihj.17-104. Epub 2017 May 23. No abstract available.

36.

Three novel BMPR2 mutations associated with advanced pulmonary arterial hypertension.

Hara H, Takeda N, Morita H, Hatano M, Amiya E, Maki H, Minatsuki S, Taki M, Shiraishi Y, Fujiwara T, Maemura S, Komuro I.

Hum Genome Var. 2017 Apr 20;4:17010. doi: 10.1038/hgv.2017.10. eCollection 2017.

37.

Authors' response to "Compound heterozygous Fukutin mutation-related non-compaction" by Finsterer and Zarrouk-Mahjoub.

Amiya E, Morita H, Ishiura H, Tsuji S, Komuro I.

Int J Cardiol. 2017 Apr 15;233:102. doi: 10.1016/j.ijcard.2017.01.107. No abstract available.

PMID:
28235473
38.

Association of the Number of HLA-DR Mismatches With Early Post-transplant Acute Cellular Rejection Among Heart Transplantation Recipients: A Cohort Study in Japanese Population.

Nitta D, Kinugawa K, Imamura T, Iino J, Endo M, Amiya E, Hatano M, Kinoshita O, Nawata K, Ono M, Komuro I.

Transplant Proc. 2017 Jan - Feb;49(1):125-129. doi: 10.1016/j.transproceed.2016.11.001.

39.

Interaction of hyperlipidemia and reactive oxygen species: Insights from the lipid-raft platform.

Amiya E.

World J Cardiol. 2016 Dec 26;8(12):689-694. doi: 10.4330/wjc.v8.i12.689.

40.

Fukutin gene mutations that cause left ventricular noncompaction.

Amiya E, Morita H, Hatano M, Nitta D, Hosoya Y, Maki H, Motozawa Y, Sato N, Ishiura H, Numakura S, Shintani Y, Kinugawa K, Takeda N, Shimizu J, Tsuji S, Komuro I.

Int J Cardiol. 2016 Nov 1;222:727-729. doi: 10.1016/j.ijcard.2016.08.011. Epub 2016 Aug 3. No abstract available.

PMID:
27521547
41.

Different Contributions of Physical Activity on Arterial Stiffness between Diabetics and Non-Diabetics.

Iwasa T, Amiya E, Ando J, Watanabe M, Murasawa T, Komuro I.

PLoS One. 2016 Aug 10;11(8):e0160632. doi: 10.1371/journal.pone.0160632. eCollection 2016.

42.

Endomyocardial Fibrosis Associated With Apical Calcification and High Uptake on Myocardial Gallium-67 Scintigraphy.

Maemura S, Amiya E, Seki H, Ueda K, Nitta D, Imamura T, Uehara M, Kawata T, Watanabe M, Hatano M, Kinugawa K, Komuro I.

Circ J. 2016 Aug 25;80(9):2053-5. doi: 10.1253/circj.CJ-16-0512. Epub 2016 Jul 29. No abstract available.

43.

Enhancement of arterial pulsation during flow-mediated dilation is impaired in the presence of ischemic heart disease.

Amiya E, Watanabe M, Watanabe S, Takata M, Komuro I.

Springerplus. 2016 Jul 16;5(1):1103. doi: 10.1186/s40064-016-2794-0. eCollection 2016.

44.

Everolimus-Incorporated Therapy Reduces Myocardial Hypertrophy in Recipients of Heart Transplantation.

Imamura T, Amiya E, Nitta D, Kinugawa K.

Int Heart J. 2016 May 25;57(3):389-90. doi: 10.1536/ihj.16-040. Epub 2016 May 13. No abstract available.

45.

Phenotypic differences in aortic stenosis according to calcification grade.

Takata M, Amiya E, Watanabe M, Shintani Y, Sakuma K, Saito A, Fukayama M, Ono M, Komuro I.

Int J Cardiol. 2016 Aug 1;216:118-20. doi: 10.1016/j.ijcard.2016.04.137. Epub 2016 Apr 26. No abstract available.

PMID:
27153135
46.

Successful Pregnancy and Delivery in a Heart Transplantation Recipient.

Nitta D, Kinugawa K, Imamura T, Endo M, Amiya E, Hatano M, Takahashi Y, Iriyama T, Kinoshita O, Nagamatsu T, Nawata K, Ono M, Komuro I.

Int Heart J. 2016 May 25;57(3):383-5. doi: 10.1536/ihj.15-414. Epub 2016 Apr 28.

47.

Novel Scoring System to Predict Ineligibility for Bridge to Implantable Left Ventricular Assist Device as Destination Therapy Before Extracorporeal Ventricular Assist Device Implantation - For the Coming Era of Destination Therapy in Japan.

Nitta D, Kinugawa K, Imamura T, Endo M, Inaba T, Maki H, Amiya E, Hatano M, Kinoshita O, Nawata K, Kyo S, Ono M.

Circ J. 2016;80(2):387-94. doi: 10.1253/circj.CJ-15-1030. Epub 2015 Dec 4.

48.

Physical Activity. A Useful Marker for Cardiac Rehabilitation?

Amiya E, Taya M, Watanabe M.

Int Heart J. 2015;56(6):583-4. doi: 10.1536/ihj.15-301. Epub 2015 Nov 9. No abstract available.

49.

Improvement of Severe Heart Failure after Endovascular Stent Grafting for Thoracic Aortic Aneurysm.

Yamaguchi T, Amiya E, Watanabe M, Komuro I.

Int Heart J. 2015;56(6):682-5. doi: 10.1536/ihj.15-171. Epub 2015 Nov 6.

50.

An Experience of Landiolol Use for an Advanced Heart Failure Patient With Severe Hypotension.

Nitta D, Kinugawa K, Imamura T, Endo M, Amiya E, Inaba T, Maki H, Hatano M, Komuro I.

Int Heart J. 2015;56(5):564-7. doi: 10.1536/ihj.15-103. Epub 2015 Sep 11.

Supplemental Content

Support Center